Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results

Go back to Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.38 -0.19 (3.41%)
Previous Close $5.57    52 Week High $18.00 
Open $5.52    52 Week Low $6.91 
Day High $5.52    P/E N/A 
Day Low $5.32    EPS $-0.67 
Volume 915,774